Omambac, Aiza .

HRN: 28-89-50  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/10/2026
CEFUROXIME 500MG (TAB)
06/10/2026
06/17/2026
PO
500
Bid
S/P NSvD
Pending Pharmacy Acceptance 

 Indication:  ProphylaxisEmpiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: